- Home
- ESEA vs STRO Comparison
ESEA vs STRO Comparison
Compare ESEA & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESEA
- STRO
- Stock Information
- Founded
- ESEA 2005
- STRO 2003
- Country
- ESEA Greece
- STRO United States
- Employees
- ESEA N/A
- STRO N/A
- Industry
- ESEA Marine Transportation
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ESEA Consumer Discretionary
- STRO Health Care
- Exchange
- ESEA Nasdaq
- STRO Nasdaq
- Market Cap
- ESEA 208.2M
- STRO 77.7M
- IPO Year
- ESEA 2006
- STRO 2018
- Fundamental
- Price
- ESEA $47.51
- STRO $0.76
- Analyst Decision
- ESEA Strong Buy
- STRO Hold
- Analyst Count
- ESEA 1
- STRO 7
- Target Price
- ESEA $62.00
- STRO $3.97
- AVG Volume (30 Days)
- ESEA 43.5K
- STRO 1.4M
- Earning Date
- ESEA 06-18-2025
- STRO 08-12-2025
- Dividend Yield
- ESEA 5.47%
- STRO N/A
- EPS Growth
- ESEA 21.86
- STRO N/A
- EPS
- ESEA 18.62
- STRO N/A
- Revenue
- ESEA $222,525,034.00
- STRO $66,434,000.00
- Revenue This Year
- ESEA $5.14
- STRO N/A
- Revenue Next Year
- ESEA $3.76
- STRO N/A
- P/E Ratio
- ESEA $2.55
- STRO N/A
- Revenue Growth
- ESEA 14.62
- STRO N/A
- 52 Week Low
- ESEA $24.58
- STRO $0.52
- 52 Week High
- ESEA $50.82
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- ESEA 71.35
- STRO 44.92
- Support Level
- ESEA $43.60
- STRO $0.67
- Resistance Level
- ESEA $47.88
- STRO $0.79
- Average True Range (ATR)
- ESEA 1.97
- STRO 0.07
- MACD
- ESEA -0.13
- STRO -0.01
- Stochastic Oscillator
- ESEA 60.30
- STRO 34.52
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.